Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
SLIHCQ Database
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
Overview
SLIHCQ Database
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Search
Articles & Reports
Key Issues
All
HEALTHCARE MARKETS
- Provider Network
-- Telehealth or Telemedicine
-- Scope of Practice
-- Any Willing Provider
-- Network Adequacy
-- Tiered Network or Narrow Network
- Competition
-- Antitrust Enforcement
-- Healthcare Consolidation
-- Most Favored Nation (MFN)
-- Certificate of Need (CON)
-- Certificate of Public Advantage (COPA)
-- Anti-Steering or Anti-Tiering
-- Non-Compete Provision
-- Price Manipulation
-- Competitive Bidding
-- Trade Secret
- Rate Regulation
- ACA Marketplace
HEALTHCARE COSTS
- Cost Containment
-- Shared Savings or Right to Shop
-- Reference Pricing
-- Prior Authorization
-- Utilization Review
- Price Gouging
- Cost-Sharing or Out-of-Pocket Costs
- High Deductible Health Plan (HDHP)
- Health Savings Account (HSA) or Health Reimbursement Account (HRA)
- Benefit Design
- Provider Payment
-- Value-Based Payment
-- Bundled Payment
-- Global Payment or Global Budget
-- Capitation
-- Population-Based Payment
-- Shared Risk or Risk-Based Payment
-- Facility Fee
HEALTHCARE SYSTEM REFORM
- COVID-19 Crisis
- Single Payer or Multi-Payer
- Public Option
- Delivery Reform
- Quality or Value-Based Reform
- Managed Competition
- Accountable Care Organization (ACO)
- Medicaid Reform or Medicaid Waiver
- Affordable Care Act (ACA)
- Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
- All-Payer Claims Database (APCD)
- Gag Clause or Non-Disclosure Agreement
- Surprise Billing or Balance Billing
- Quality Measure
PHARMACEUTICALS
- Drug Pricing
- Drug Formulary
- Pharmacy Benefit Manager (PBM)
- Pharmacy Regulation
-- Clawback Restriction
- Biosimilar or Generic Competition
-- Generic Competition Block or Delay
- Therapeutic Substitution
- Medicaid Pharmaceuticals
- Medicare Part D
- 340B Drug Pricing Program
- Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
Economic Inquiry
Price Effects of a Merger: Evidence from a Physicians’ Market
February 25, 2021
RAND
Increasing Price Transparency in Health Care: Key Themes and Policy Options from a Technical Expert Panel
February 23, 2021
National Bureau of Economic Research
Does Private Equity Investment in Healthcare Benefit Patients? Evidence from Nursing Homes
February 22, 2021
NEJM
Telemedicine and Medical Licensure — Potential Paths for Reform
February 20, 2021
Urban Institute
Impacts of the ACA’s Medicaid Expansion on Health Insurance Coverage and Health Care Access among Young Adults
February 18, 2021
RAND
Impact of Policy Options for Reducing Hospital Prices Paid by Private Health Plans
February 18, 2021
Kaiser Family Foundation
Impact of Key Provisions of the House COVID-19 Relief Proposal on Marketplace Premiums
February 18, 2021
Leonard Davis Institute of Health Economics
The Future of Value-Based Payment: A Road Map to 2030
February 17, 2021
The Commonwealth Fund
Federal Policy Priorities for Preserving and Improving Access to Coverage: Perspectives from State-Based Marketplaces
February 17, 2021
Health Affairs Blog
Congressional Budget Office Scores Medicare-For-All: Universal Coverage For Less Spending
February 16, 2021
National Bureau of Economic Research
The Health Costs of Cost-Sharing
February 8, 2021
Urban Institute
Rationalizing a Medicare Buy-In Policy for Adults Ages 50 to 64 That Builds on the ACA
February 3, 2021
Health Affairs
Annual Out-Of-Pocket Spending Clusters Within Short Time Intervals: Implications For Health Care Affordability
February 1, 2021
Health Affairs
Beyond The High Prices Of Prescription Drugs: A Framework To Assess Costs, Resource Allocation, And Public Funding
February 1, 2021
Health Affairs
The Impact Of Medicare On Access To And Affordability Of Health Care
February 1, 2021
Health Affairs
Variation In Telemedicine Use And Outpatient Care During The COVID-19 Pandemic In The United States
February 1, 2021
Next
